UBS lowered the firm’s price target on Estee Lauder (EL) to $107 from $119 and keeps a Neutral rating on the shares. Estee Lauder posted a solid Q2 EPS beat and raised FY26 guidance on stronger sales and margins, confirming improved fundamentals versus recent years, though elevated expectations for a faster earnings recovery, and a muted implied top-line acceleration drove skepticism, suggesting the stock needs either a better entry point or clearer growth visibility, the analyst tells investors in a research note.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on EL:
- Estee Lauder price target lowered to $94 from $100 at Barclays
- Estee Lauder upgraded to Buy from Neutral at Citi
- Estée Lauder: Depressed Valuation, Improving Fundamentals and Margin Upside Support 30% Re‑Rating Potential
- Morning Movers: Ralph Lauren and Qualcomm sink after earnings
- Estee Lauder reports Q2 adjusted EPS 89c, consensus 83c
